District Court Opinion Underscores Importance of Careful Drafting of Settlement Agreements

Jan 12, 2015

Reading Time : 1 min

Unfortunately, the relationship soured, which led to litigation and mediation. In 2013, the parties settled. The settlement agreement included, among other things, two seemingly straightforward provisions regarding inventorship and validity:

Inventorship Provision: “[E]ach party agrees that he will not remove or replace the other party from the patent.”

Validity Provision: “To avoid any possible confusion, notwithstanding anything to the contrary herein, nothing in this agreement shall be deemed to prevent a party from taking any action to maintain or ensure the validity of the patent.”

In 2014, Mr. Crain sued Mr. DeBartolo seeking to remove him as a joint inventor of the beer cozy patent pursuant to 35 U.S.C. § 256. Mr. DeBartolo counterclaimed for breach of the settlement agreement and moved for summary judgment, arguing that the inventorship provision of the settlement agreement plainly barred Mr. Crain’s correction­of­inventorship lawsuit. The court disagreed, reasoning that Mr. Crain’s lawsuit qualified as an “action to maintain or ensure the validity of the patent” (because incorrect inventorship may void the patent), and therefore the validity provision permitted Mr. Crain’s lawsuit “notwithstanding anything to the contrary” in the agreement, including the inventorship provision. In effect, the court concluded that the “notwithstanding” language in the validity provision “trump[ed] conflicting language” in the inventorship provision.

This decision serves a valuable reminder: do not lose the forest for the trees when negotiating and finalizing settlement agreements. Make sure the various provisions work together harmoniously, or there may be trouble down the road.

Crain v. DeBartolo, No. 7:14–CV–29–D, 2015 WL 73961 (E.D.N.C. Jan. 6, 2015) (Dever, C.J.).

Share This Insight

Categories

Previous Entries

IP Newsflash

July 22, 2026

The Court of Federal Claims recently denied the United States’ motion to dismiss a patent infringement suit related to production of a COVID-19 vaccine. The court held that it had jurisdiction because the plaintiff filed its claim there before it filed a parallel suit in a district court and because it adequately pleaded the government’s involvement.

...

Read More

IP Newsflash

July 13, 2026

In a precedential and sua sponte Director Review decision, USPTO Director Squires recently vacated three related institution decisions nearly six months after institution where a district court later found the challenged claims invalid. Because the fourteen-day deadline to request Director Review of the institution decisions had passed, the Director used this opportunity to formally extend the deadline in two ways. First, he extended the fourteen-day deadline under 37 C.F.R. § 42.75(c)(1) to thirty days, which “puts requests for Director Review of decisions to institute trial on equal footing to requests for Director Review of final decisions or decisions not to institute trial.” Second, he outlined certain “exceptional circumstances” that warrant a further extension of the deadline to account for changes in the case that “surface after the deadline.” In the case at hand, the Director found the district court’s invalidity finding to be such an “exceptional circumstance” and ultimately initiated review and vacated the institution decisions on that basis.

...

Read More

IP Newsflash

June 5, 2026

The Supreme Court unanimously held that for a complaint of induced infringement, a patent owner must allege that the accused infringer took affirmative, not passive, steps to encourage direct infringement. Thus, where a generic drug has a skinny label, to induce infringement of the carved-out patented use of the drug, the generic company must have taken steps that were designed to cause others to perform the patented use, not just steps that could cause such conduct.

...

Read More

IP Newsflash

May 07, 2026

The Northern District of Illinois granted a summary judgment motion of no invalidity based on indefiniteness because the qualitative terms like “sufficiently slow” and “desired period of time” were definite when viewed in light of the surrounding claim language and specification.

...

Read More

© 2026 Akin Gump Strauss Hauer & Feld LLP. All rights reserved. Attorney advertising. This document is distributed for informational use only; it does not constitute legal advice and should not be used as such. Prior results do not guarantee a similar outcome. Akin is the practicing name of Akin Gump LLP, a New York limited liability partnership authorized and regulated by the Solicitors Regulation Authority under number 267321. A list of the partners is available for inspection at Eighth Floor, Ten Bishops Square, London E1 6EG. For more information about Akin Gump LLP, Akin Gump Strauss Hauer & Feld LLP and other associated entities under which the Akin Gump network operates worldwide, please see our Legal Notices page.